César Margarit

903 total citations
49 papers, 684 citations indexed

About

César Margarit is a scholar working on Anesthesiology and Pain Medicine, Physiology and Pharmacology. According to data from OpenAlex, César Margarit has authored 49 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Anesthesiology and Pain Medicine, 17 papers in Physiology and 16 papers in Pharmacology. Recurrent topics in César Margarit's work include Pain Management and Opioid Use (30 papers), Pain Mechanisms and Treatments (16 papers) and Opioid Use Disorder Treatment (15 papers). César Margarit is often cited by papers focused on Pain Management and Opioid Use (30 papers), Pain Mechanisms and Treatments (16 papers) and Opioid Use Disorder Treatment (15 papers). César Margarit collaborates with scholars based in Spain, Sweden and United Kingdom. César Margarit's co-authors include Ana M. Peiró, Javier Muriel, Pura Ballester, Philippe Mavrocordatos, Giustino Varrassi, Brent R. Collett, Karsten Ahlbeck, Gerhard Müller-Schwefe, Bart Morlion and W. Jaksch and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

César Margarit

46 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
César Margarit Spain 15 290 259 250 148 122 49 684
Renato Vellucci Italy 13 230 0.8× 247 1.0× 210 0.8× 141 1.0× 147 1.2× 34 764
G. Vorsanger United States 15 241 0.8× 228 0.9× 280 1.1× 152 1.0× 38 0.3× 29 640
Errol Gould United States 16 259 0.9× 109 0.4× 188 0.8× 88 0.6× 72 0.6× 47 755
Lindy J. Roberts Australia 7 121 0.4× 229 0.9× 141 0.6× 162 1.1× 84 0.7× 13 539
A. J. Clark Canada 14 381 1.3× 196 0.8× 244 1.0× 89 0.6× 133 1.1× 24 833
Sanjeet Narang United States 9 318 1.1× 210 0.8× 176 0.7× 161 1.1× 119 1.0× 17 691
Qinfang Xiang United States 15 111 0.4× 178 0.7× 164 0.7× 199 1.3× 48 0.4× 32 564
Timothy Furnish United States 17 184 0.6× 270 1.0× 106 0.4× 166 1.1× 108 0.9× 40 824
Bernd Lange Germany 13 401 1.4× 430 1.7× 662 2.6× 342 2.3× 56 0.5× 33 1.1k
Simon Haroutiunian Israel 10 186 0.6× 213 0.8× 168 0.7× 76 0.5× 123 1.0× 19 767

Countries citing papers authored by César Margarit

Since Specialization
Citations

This map shows the geographic impact of César Margarit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César Margarit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César Margarit more than expected).

Fields of papers citing papers by César Margarit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César Margarit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César Margarit. The network helps show where César Margarit may publish in the future.

Co-authorship network of co-authors of César Margarit

This figure shows the co-authorship network connecting the top 25 collaborators of César Margarit. A scholar is included among the top collaborators of César Margarit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with César Margarit. César Margarit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Muriel, Javier, et al.. (2024). Epigenetic and sex differences in opioid use disorder in chronic pain: A real‐world study linked with OPRM1 DNA methylation. Addiction Biology. 29(7). e13422–e13422. 3 indexed citations
4.
Muriel, Javier, et al.. (2024). Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach. Minerva Anestesiologica. 90(5). 386–396. 2 indexed citations
5.
Langford, R. M., et al.. (2024). Co-crystal of tramadol–celecoxib (CTC) for acute moderate-to-severe pain. Current Medical Research and Opinion. 40(3). 455–468. 9 indexed citations
6.
Muriel, Javier, et al.. (2023). Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta Pharmaceutica. 73(2). 227–241. 4 indexed citations
7.
Muriel, Javier, César Margarit, Marí­a José Herrero, et al.. (2023). Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain. Journal of Clinical Medicine. 12(10). 3449–3449. 9 indexed citations
8.
Muriel, Javier, et al.. (2023). Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study. International Journal of Molecular Sciences. 24(13). 10754–10754. 14 indexed citations
9.
Muriel, Javier, et al.. (2023). Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences. Frontiers in Pharmacology. 14. 1200430–1200430. 8 indexed citations
10.
Margarit, César, et al.. (2022). Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study. Acta Pharmaceutica. 72(4). 529–545. 1 indexed citations
11.
Margarit, César, et al.. (2022). Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study. Biomedicines. 10(10). 2468–2468. 7 indexed citations
12.
Margarit, César, et al.. (2022). Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study. Scientific Reports. 12(1). 10126–10126. 12 indexed citations
13.
Escobar, Yolanda, César Margarit, Concepción Pérez, T. Quintanar, & Juan Antonio Virizuela. (2022). Good practice recommendations to better coordinate the management of oncological pain: a Delphi survey. Scientific Reports. 12(1). 22459–22459. 3 indexed citations
14.
Segura, Ana, Pura Ballester, Antonio Urbano, et al.. (2019). Endothelial nitric oxide synthase gene polymorphisms and erectile dysfunction in chronic pain. Gene. 721. 100005–100005. 4 indexed citations
15.
Montes, Antônio, et al.. (2017). Management of postoperative pain in Spain: a nationwide survey of practice. Acta Anaesthesiologica Scandinavica. 61(5). 480–491. 15 indexed citations
16.
Segura, Ana, et al.. (2017). Disfunción eréctil en pacientes con dolor crónico tratados con opioides. Medicina Clínica. 149(2). 49–54. 10 indexed citations
17.
Julià-Torras, Joaquim, et al.. (2013). Relationship between the pharmacokinetic properties and efficacy of fentanyl pectin nasal spray in breakthrough cancer pain. 15(1). 40–45.
18.
Margarit, César, Antonio Antón, Yolanda Escobar, et al.. (2012). Breakthrough cancer pain – still a challenge. Journal of Pain Research. 5. 559–559. 32 indexed citations
19.
Escobar, Yolanda, Joaquim Julià-Torras, Rafael Gálvez, et al.. (2012). Optimal management of breakthrough cancer pain (BCP). Clinical & Translational Oncology. 15(7). 526–534. 9 indexed citations
20.
Varrassi, Giustino, Gerhard Müller-Schwefe, Joseph V. Pergolizzi, et al.. (2010). Pharmacological treatment of chronic pain – the need for CHANGE. Current Medical Research and Opinion. 26(5). 1231–1245. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026